Rossari Biotech Limited Total Liabilities

Latest as of September 2025: Rs8.36 Billion INR ≈ $90.46 Million USD

Rossari Biotech Limited total liabilities. Based on the latest financial reports, Rossari Biotech Limited (ROSSARI) has total liabilities worth Rs8.36 Billion INR (≈ $90.46 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Rossari Biotech Limited (ROSSARI) asset resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Rossari Biotech Limited (2017–2025)

Total liabilities of Rossari Biotech Limited from 2017 to 2025. This chart illustrates how Rossari Biotech Limited's total liabilities have evolved over time, based on quarterly financial data.

Rossari Biotech Limited Competitors by Total Liabilities

The table below lists competitors of Rossari Biotech Limited ranked by their total liabilities.

Company	Country	Total Liabilities
Crescendo Corporation Bhd KLSE:6718	Malaysia	RM534.99 Million
Pioneer High Income Closed Fund NYSE:PHT	USA	$116.53 Million
Cypherpunk Technologies Inc. NASDAQ:CYPH	USA	$3.65 Million
Xxentria Technology Materials Co Ltd TWO:8942	Taiwan	NT$3.75 Billion
SC Asset Corporation Public Company Limited BK:SC	Thailand	฿44.31 Billion
G1 Secure Solutions Ltd TA:GOSS	Israel	ILA510.23 Million
Panca Budi Idaman Tbk PT JK:PBID	Indonesia	Rp725.77 Billion

Liability Composition Analysis (2017–2025)

This chart breaks down Rossari Biotech Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see ROSSARI total assets.

Liquidity & Leverage Metrics

Rossari Biotech Limited Total Liabilities Ratios Explained

Rossari Biotech Limited total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.73	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.67	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.40	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Rossari Biotech Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Rossari Biotech Limited (2017–2025)

The table below shows the annual total liabilities of Rossari Biotech Limited from 2017 to 2025.

Year	Total Liabilities	Change
2025-03-31	Rs7.11 Billion ≈ $76.86 Million	+35.53%
2024-03-31	Rs5.24 Billion ≈ $56.71 Million	+15.92%
2023-03-31	Rs4.52 Billion ≈ $48.93 Million	+0.19%
2022-03-31	Rs4.52 Billion ≈ $48.83 Million	+195.96%
2021-03-31	Rs1.53 Billion ≈ $16.50 Million	-17.45%
2020-03-31	Rs1.85 Billion ≈ $19.99 Million	+46.66%
2019-03-31	Rs1.26 Billion ≈ $13.63 Million	+61.85%
2018-03-31	Rs778.70 Million ≈ $8.42 Million	+13.00%
2017-03-31	Rs689.09 Million ≈ $7.45 Million	--

About Rossari Biotech Limited

NSE:ROSSARI India Specialty Chemicals

Market Cap

$243.97 Million

Rs22.56 Billion INR

Market Cap Rank

#15528 Global

#786 in India

Share Price

Rs407.35

Change (1 day)

+0.28%

52-Week Range

Rs378.60 - Rs640.20

All Time High

Rs1568.62